Sustained clinical remission despite suboptimal molecular response to imatinib in e1a2 BCR-ABL chronic myeloid leukemia

被引：0

作者：

Langabeer, Stephen E. ^{[1
]}

Crampe, Mireille

Haslam, Karl

Kelly, Johanna ^{[2
]}

Cahill, Mary R. ^{[3
]}

机构：

[1] St James Hosp, Cent Pathol Lab, Dublin 8, Ireland

[2] Our Ladys Childrens Hosp, Natl Ctr Med Genet, Dublin, Ireland

[3] Cork Univ Hosp, Dept Haematol, Cork, Ireland

来源：

LEUKEMIA RESEARCH | 2010年 / 34卷 / 07期

关键词：

CHRONIC MYELOGENOUS LEUKEMIA; TRANSCRIPTS; RECOMMENDATIONS; P190(BCR-ABL);

D O I：

10.1016/j.leukres.2010.01.025

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：E176 / E177

页数：2

共 11 条

[1] First and second line imatinib treatment in chronic myelogenous leukemia patients expressing rare e1a2 or e19a2 BCR-ABL transcripts [J].

Andrikovics, Hajnalka ;

Nahajevszky, Sarolta ;

Szilvasi, Aniko ;

Bors, Andras ;

Adam, Emma ;

Kozma, Andras ;

Kajtar, Bela ;

Barta, Aniko ;

Poros, Anna ;

Tordai, Attila .

HEMATOLOGICAL ONCOLOGY, 2007, 25 (03) :143-147

[2] Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet [J].

Baccarani, Michele ;

Saglio, Giuseppe ;

Goldman, John ;

Hochhaus, Andreas ;

Simonsson, Bengt ;

Appelbaum, Frederick ;

Apperley, Jane ;

Cervantes, Francisco ;

Cortes, Jorge ;

Deininger, Michael ;

Gratwohl, Alois ;

Guilhot, Frangois ;

Horowitz, Mary ;

Hughes, Timothy ;

Kantarjian, Hagop ;

Larson, Richard ;

Niederwieser, Dielger ;

Silver, Richard ;

Hehlmann, Rudiger .

BLOOD, 2006, 108 (06) :1809-1820

[3] Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia -: A Europe Against Cancer Program [J].

Gabert, J ;

Beillard, E ;

van der Velden, VHJ ;

Bi, W ;

Grimwade, D ;

Pallisgaard, N ;

Barbany, G ;

Cazzaniga, G ;

Cayuela, JM ;

Cavé, H ;

Pane, F ;

Aerts, JLE ;

De Micheli, D ;

Thirion, X ;

Pradel, V ;

González, M ;

Viehmann, S ;

Malec, M ;

Saglio, G ;

van Dongen, JJM .

LEUKEMIA, 2003, 17 (12) :2318-2357

[4] Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia [J].

Hochhaus, A. ;

O'Brien, S. G. ;

Guilhot, F. ;

Druker, B. J. ;

Branford, S. ;

Foroni, L. ;

Goldman, J. M. ;

Mueller, M. C. ;

Radich, J. P. ;

Rudoltz, M. ;

Mone, M. ;

Gathmann, I. ;

Hughes, T. P. ;

Larson, R. A. .

LEUKEMIA, 2009, 23 (06) :1054-1061

[5] Monitoring CML patients responding to treatment with tyrosine kinase inhibitors:: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results [J].

Hughes, Timothy ;

Deininger, Michael ;

Hochhaus, Andreas ;

Branford, Susan ;

Radich, Jerald ;

Kaecla, Jaspal ;

Baccarani, Michele ;

Cortes, Jorge ;

Cross, Nicholas C. P. ;

Druker, Brian J. ;

Gabert, Jean ;

Grimwade, David ;

Hehlmann, Ruediger ;

Kamel-Reid, Suzanne ;

Lipton, Jeffrey H. ;

Longtine, Janina ;

Martinelli, Giovanni ;

Saglio, Giuseppe ;

Soverini, Simona ;

Stock, Wendy ;

Goldman, John M. .

BLOOD, 2006, 108 (01) :28-37

[6] Lymphoid preponderance and the absence of basophilia and splenomegaly are frequent in m-bcr-positive chronic myelogenous leukemia [J].

Hur, M ;

Song, EY ;

Kang, SH ;

Shin, DH ;

Kim, JY ;

Park, SS ;

Cho, HI .

ANNALS OF HEMATOLOGY, 2002, 81 (04) :219-223

[7] Philadelphia chromosome-positive chronic myeloid leukemia expressing p190BCR-ABL [J].

Ohsaka, A ;

Shiina, S ;

Kobayashi, M ;

Kudo, H ;

Kawaguchi, R .

INTERNAL MEDICINE, 2002, 41 (12) :1183-1187

[8] Chronic myeloid leukemia with p190BCR-ABL: prevalence, morphology, tyrosine kinase inhibitor response, and kinase domain mutation analysis [J].

Pardanani, Animesh ;

Tefferi, Ayalew ;

Litzow, Mark R. ;

Zent, Clive ;

Hogan, William J. ;

McClure, Rebecca F. ;

Viswanatha, David .

BLOOD, 2009, 114 (16) :3502-3503

[9] Molecular biology of bcr-abl1-positive chronic myeloid leukemia [J].

Quintas-Cardama, Alfonso ;

Cortes, Jorge .

BLOOD, 2009, 113 (08) :1619-1630

[10] Chronic myelogenous leukaemia with p185BCR/ABL expression:: characteristics and clinical significance [J].

Ravandi, F ;

Cortes, J ;

Albitar, M ;

Arlinghaus, R ;

Guo, JQ ;

Talpaz, M ;

Kantarjian, HM .

BRITISH JOURNAL OF HAEMATOLOGY, 1999, 107 (03) :581-586

← 1 2 →